Related Articles
Effects of different CYP2C19 genotypes on prognosis of patients complicated with atrial fibrillation taking clopidogrel after PCI
Analysis of thrombelastogram-guided medication in patients with coronary heart disease after percutaneous coronary intervention
Clinical effect of ticagrelor administered in acute coronary syndrome patients following percutaneous coronary intervention
Spontaneous intermuscular hematoma in a patient receiving ticagrelor and aspirin: A case report
Rosuvastatin plus ticagrelor decreases the risk of major adverse cardiovascular events and elevates cardiac function compared with ticagrelor alone in patients undergoing percutaneous coronary intervention: A meta‑analysis